1. Home
  2. AMRN

as 05-22-2024 3:35pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Founded: N/A Country:
Ireland
Ireland
Employees: N/A City: DUBLIN 2
Market Cap: 357.5M IPO Year: 1993
Target Price: $1.08 AVG Volume (30 days): 1.5M
Analyst Decision: Sell Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.13 EPS Growth: N/A
52 Week Low/High: $0.65 - $1.49 Next Earning Date: 05-01-2024
Revenue: $277,455,000 Revenue Growth: -23.04%
Revenue Growth (this year): -26.05% Revenue Growth (next year): 4.35%

Share on Social Networks:

Stock Insider Trading Activity of Amarin Corporation plc (AMRN)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Holt Patrick AMRN President and CEO Jan 22 '24 Buy $1.09 14,426 $15,724.34 314,426 SEC Form 4